Pacritinib With Standard of Care Azacitidine or Decitabine as a Bridge to Allogeneic Hematopoietic Stem Cell Transplant for Patients With Accelerated and Blast Phase Myeloproliferative Neoplasms

NCT07148947 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Accelerated Phase Myeloproliferative Neoplasm
Blast Phase Myeloproliferative Neoplasm

Interventions

DRUG: Pacritinib
DRUG: Decitabine
DRUG: Decitabine and Cedazuridine
DRUG: Azacitidine
OTHER: Survey Administration
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy

Sponsor

University of Washington

Collaborators

[object Object]